Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery. (avaa uuden ikkunan)

Elbohoty AE, Mohammed WE, Sweed M, Bahaa Eldin AM, Nabhan A, Abd-El-Maeboud KH.

Lähde‎: Int J Gynaecol Obstet 2016;134(3):324-8.

Arkistoitu‎: PubMed 27350226

https://www.ncbi.nlm.nih.gov/pubmed/27350226 (avaa uuden ikkunan)

Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. (avaa uuden ikkunan)

Gallos ID, Williams HM, Price MJ, Merriel A, Gee H, Lissauer D, Moorthy V, Tobias A, Deeks JJ, Widmer M, Tunçalp Ö, Gulmezoglu AM, Hofmeyr GJ, Coomarasamy A

Lähde‎: Cochrane Database Syst Rev 2018;4:CD011689.

Arkistoitu‎: PubMed 29693726

DOI‎: 10.1002/14651858.CD011689.pub2

https://www.ncbi.nlm.nih.gov/pubmed/29693726 (avaa uuden ikkunan)

Preventing postpartum hemorrhage after cesarean delivery: A network meta-analysis of available pharmacologic agents. (avaa uuden ikkunan)

Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT

Lähde‎: Am J Obstet Gynecol.

Arkistoitu‎: PubMed 34534498

DOI‎: 10.1016/j.ajog.2021.08.060

https://pubmed.ncbi.nlm.nih.gov/34534498/ (avaa uuden ikkunan)

A randomised controlled trial comparing oxytocin and oxytocin + ergometrine for prevention of postpartum haemorrhage at caesarean section. (avaa uuden ikkunan)

Koen S, Snyman LC, Pattinson RC, Makin JA.

Lähde‎: S Afr Med J 2016;106(4):399-402.

Arkistoitu‎: PubMed 27032858

https://www.ncbi.nlm.nih.gov/pubmed/27032858 (avaa uuden ikkunan)

Prophylactic use of ergot alkaloids in the third stage of labour. (avaa uuden ikkunan)

Liabsuetrakul T, Choobun T, Peeyananjarassri K, Islam QM.

Lähde‎: Cochrane Database Syst Rev 2007;(2):CD005456.

Arkistoitu‎: PubMed 17443592

https://www.ncbi.nlm.nih.gov/pubmed/17443592 (avaa uuden ikkunan)

Treatment for primary postpartum haemorrhage. (avaa uuden ikkunan)

Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z.

Lähde‎: Cochrane Database Syst Rev 2014;(2):CD003249.

Arkistoitu‎: PubMed 24523225

https://www.ncbi.nlm.nih.gov/pubmed/24523225 (avaa uuden ikkunan)

Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: a randomized controlled trial. (avaa uuden ikkunan)

Munn MB, Owen J, Vincent R, Wakefield M, Chestnut DH, Hauth JC.

Lähde‎: Obstet Gynecol 2001;98(3):386-90.

Arkistoitu‎: PubMed 11530117

https://www.ncbi.nlm.nih.gov/pubmed/11530117 (avaa uuden ikkunan)

Prospective randomized trial of oxytocin administration for active management of the third stage of labor. (avaa uuden ikkunan)

Oguz Orhan E, Dilbaz B, Aksakal SE, Altınbas S, Erkaya S.

Lähde‎: Int J Gynaecol Obstet 2014;127(2):175-9.

Arkistoitu‎: PubMed 25108586

https://www.ncbi.nlm.nih.gov/pubmed/25108586 (avaa uuden ikkunan)

A randomized clinical trial of preoperative versus postoperative misoprostol in elective cesarean delivery. (avaa uuden ikkunan)

Ragab A, Barakat R, Alsammani MA.

Lähde‎: Int J Gynaecol Obstet 2016;132(1):82-4.

Arkistoitu‎: PubMed 26522140

DOI‎: 10.1016/j.ijgo.2015.06.057

https://www.ncbi.nlm.nih.gov/pubmed/26522140 (avaa uuden ikkunan)

Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. (avaa uuden ikkunan)

Roach MK, Abramovici A, Tita AT.

Lähde‎: Am J Perinatol 2013;30(7):523-8.

Arkistoitu‎: PubMed 23208766

https://www.ncbi.nlm.nih.gov/pubmed/23208766 (avaa uuden ikkunan)

Prostaglandin E2 analogue sulprostone for treatment of atonic postpartum hemorrhage. (avaa uuden ikkunan)

Schmitz T, Tararbit K, Dupont C, Rudigoz RC, Bouvier-Colle MH, Deneux-Tharaux C; Pithagore6 Group.

Lähde‎: Obstet Gynecol 2011;118(2 Pt 1):257-65.

Arkistoitu‎: PubMed 21775840

DOI‎: 10.1097/AOG.0b013e3182255335

https://www.ncbi.nlm.nih.gov/pubmed/21775840 (avaa uuden ikkunan)

The effects of a peripartum strategy to prevent and treat primary postpartum haemorrhage at health facilities in Niger: a longitudinal, 72-month study. (avaa uuden ikkunan)

Seim AR, Alassoum Z, Souley I, Bronzan R, Mounkaila A, Ahmed LA

Lähde‎: Lancet Glob Health. 2023 11(2):e287-e295.

Arkistoitu‎: PubMed 36669809

DOI‎: 10.1016/S2214-109X(22)00518-6.

https://pubmed.ncbi.nlm.nih.gov/36669809/ (avaa uuden ikkunan)

Intravenous sulprostone infusion in the treatment of retained placenta. (avaa uuden ikkunan)

Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M.

Lähde‎: Acta Obstet Gynecol Scand 2013;92(4):426-32.

Arkistoitu‎: PubMed 22862433

DOI‎: 10.1111/j.1600-0412.2012.01506.x

https://www.ncbi.nlm.nih.gov/pubmed/22862433 (avaa uuden ikkunan)

Carbetocin for preventing postpartum haemorrhage. (avaa uuden ikkunan)

Su LL, Chong YS, Samuel M.

Lähde‎: Cochrane Database Syst Rev 2012;(4):CD005457.

Arkistoitu‎: PubMed 22513931

https://www.ncbi.nlm.nih.gov/pubmed/22513931 (avaa uuden ikkunan)

Prostaglandins for preventing postpartum haemorrhage. (avaa uuden ikkunan)

Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM.

Lähde‎: Cochrane Database Syst Rev 2012;(8):CD000494.

Arkistoitu‎: PubMed 22895917

DOI‎: 10.1002/14651858.CD000494.pub4

https://www.ncbi.nlm.nih.gov/pubmed/22895917 (avaa uuden ikkunan)

Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. (avaa uuden ikkunan)

Westhoff G, Cotter AM, Tolosa JE.

Lähde‎: Cochrane Database Syst Rev 2013;(10):CD001808.

Arkistoitu‎: PubMed 24173606

DOI‎: 10.1002/14651858.CD001808.pub2

https://www.ncbi.nlm.nih.gov/pubmed/24173606 (avaa uuden ikkunan)